Sinai Health

As we continue our journey to build Sinai Health System, an integrated health care system that has brought together Mount Sinai Hospital, Bridgepoint, the Lunenfeld-Tanenbaum Research Institute (ltri) and Circle of Care, we think about the possibilities for the people for whom we care. Our new model of care promises better coordination and transition between types of care, focusing on the broad health needs of those with the most complex conditions. At Sinai Health System, we are committed to making sure that no matter the diagnosis, the journey for those affected is a seamless one. This commitment is already a hallmark of many of our programs, especially in cancer. For this reason, this issue of our magazine features stories focused on cancer, one of the most devastating and prevalent categories of diseases affecting Canadians. Cancer has touched every one of us in some shape or form, and two out of every five Canadians will develop cancer in their lifetime — a staggering statistic. Tackling these diseases head on requires the extraordinary brains and brawn of our clinical and research talent and the vision of donors committed to partnering with us. Sinai Health System's Christopher Sharp Cancer Centre excels in complex cancer care that brings hope and healing to people and their families facing this difficult diagnosis. We have one of the largest specialized cancer programs in Ontario and we treat cancers that can be challenging, fast-spreading and complex — breast, bladder, prostate, gastrointestinal, endocrine, gynaecologic and head and neck cancers, as well as sarcomas. We are at the forefront of cancer care that transforms the experience for the thousands who turn to us for state-of-the-art surgery, chemotherapy and new therapies. Though there are more than one hundred types of cancer, they all start in more or less the same way, when cells in the body start growing uncontrollably. But what if we could unravel the mysteries behind how a tumour forms and how it spreads? More than 40 per cent of our research at the LTRI focuses on these types of questions, and our discoveries are advancing cancer research and treatment around the world. Exploring these important questions is incredibly expensive — $2,500 in donor support is required each and every hour of the day to propel our discovery science teams. Government grant funding alone cannot support the talent and equipment necessary to bring bold ideas to life. Rather, our essential work has been fuelled by philanthropic leaders like Isadore and Rosalie Sharp whose transformational gifts totalling $20 million created the Christopher Sharp Cancer Centre, allowing us to combine our renowned oncology programs under one umbrella. Within the Sharp Centre, the Marvelle Koffler Breast Centre, the first of its kind, is celebrating its 20th anniversary; we salute Marvelle Koffler, the visionary behind the Centre, and applaud the compassionate care and breakthroughs for which it is known. The Murray Koffler Urologic Wellness Centre, established through a visionary investment by Murray and Marvelle Koffler, is today a world leader in bladder, prostate, kidney and testicular cancers. Our leadership in cancer care and research has resulted in more people beating cancer and living longer lives — a major victory that inspires our continued work. Because of the support of our community, we are poised for even greater innovation and impact. Yours sincerely and with appreciation, Brent S. Belzberg Chair, Board of Directors, Mount Sinai Hospital Foundation of Toronto Kevin R. Goldthorp CEO, Mount Sinai Hospital Foundation of Toronto Executive Vice-President, Advancement & Marketing, Sinai Health System Message from our Leaders TO SUPPORT CANCER CARE AND RESEARCH, PLEA SE VISIT: supportsinai.ca/bestmedicine 1

• Cover